- Home
- RNA vs NBIS Comparison
RNA vs NBIS Comparison
Compare RNA & NBIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- NBIS
- Stock Information
- Founded
- RNA 2012
- NBIS 2000
- Country
- RNA United States
- NBIS Netherlands
- Employees
- RNA N/A
- NBIS N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- NBIS
- Sector
- RNA Health Care
- NBIS
- Exchange
- RNA Nasdaq
- NBIS NYSE
- Market Cap
- RNA 4.4B
- NBIS 4.8B
- IPO Year
- RNA 2020
- NBIS 2011
- Fundamental
- Price
- RNA $29.31
- NBIS $47.97
- Analyst Decision
- RNA Strong Buy
- NBIS Strong Buy
- Analyst Count
- RNA 14
- NBIS 3
- Target Price
- RNA $68.00
- NBIS $60.67
- AVG Volume (30 Days)
- RNA 1.4M
- NBIS 16.3M
- Earning Date
- RNA 08-08-2025
- NBIS 07-30-2025
- Dividend Yield
- RNA N/A
- NBIS N/A
- EPS Growth
- RNA N/A
- NBIS N/A
- EPS
- RNA N/A
- NBIS N/A
- Revenue
- RNA $8,927,000.00
- NBIS $161,400,000.00
- Revenue This Year
- RNA N/A
- NBIS $38,469.36
- Revenue Next Year
- RNA $155.06
- NBIS $106.37
- P/E Ratio
- RNA N/A
- NBIS N/A
- Revenue Growth
- RNA N/A
- NBIS N/A
- 52 Week Low
- RNA $21.51
- NBIS $14.09
- 52 Week High
- RNA $56.00
- NBIS $55.04
- Technical
- Relative Strength Index (RSI)
- RNA 42.04
- NBIS N/A
- Support Level
- RNA $31.59
- NBIS N/A
- Resistance Level
- RNA $38.00
- NBIS N/A
- Average True Range (ATR)
- RNA 2.01
- NBIS 0.00
- MACD
- RNA -0.59
- NBIS 0.00
- Stochastic Oscillator
- RNA 9.67
- NBIS 0.00
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About NBIS NEBIUS GROUP N V
Nebius Group NV is a tech company. It is a European provider of infrastructure and services to AI builders globally. The group builds full-stack infrastructure to service the growth of the AI industry, including the scale of GPU clusters, cloud platforms, tools, and services for developers. It has R&D hubs across Europe, North America and Israel.